Distribution of Clostridium difficile PCR ribotypes and high proportion of 027 and 176 in some hospitals in four South Eastern European countries

Anaerobe

Volumn 42, Issue , 2016, Pages 142-144

  Rupnik, Maja ^a,b   Tambic Andrasevic, Arjana ^c   Trajkovska Dokic, Elena ^d   Matas, Ivanka ^e   Jovanovic, Milica ^f   Pasic, Selma ^g   Kocuvan, Aleksander ^b   Janezic, Sandra ^a,b  

^a National Laboratory for Health   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c Croatia   (Croatia)

^d SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^e Institute of Public Health   (Croatia)

^f CLINICAL CENTER OF SERBIA   (Serbia)

^g Jasika   (Croatia)

Author keywords

Clostridium difficile; Endemic ribotypes; Outbreak; Ribotype 027; Ribotype 176

Indexed keywords

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BOSNIA AND HERZEGOVINA; CROATIA; HUMAN; MACEDONIA (REPUBLIC); NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOTYPING; SERBIA; CLASSIFICATION; EASTERN EUROPE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EPIDEMIC; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY;

CLOSTRIDIUM DIFFICILE; DISEASE OUTBREAKS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EUROPE, EASTERN; HOSPITALS; HUMANS; POLYMERASE CHAIN REACTION; RIBOTYPING;

EID: 84994236202     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2016.10.005     Document Type: Article

References (18)

1. [1] Magill, S.S., Edwards, J.R., Bamberg, W., Beldavs, Z.G., Dumyati, G., Kainer, M.A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., Ray, S.M., Thompson, D.L., Wilson, L.E., Fridkin, S.K., Emerging infections program healthcare-associated infections and antimicrobial use prevalence survey team, multistate point-prevalence survey of health care-associated infections. N. Engl. J. Med. 370 (2014), 1198–1208, 10.1056/NEJMoa1306801.
2. [2] Martin, J.S.H., Monaghan, T.M., Wilcox, M.H., Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 206–216, 10.1038/nrgastro.2016.25.
3. [3] Kuijper, E.J., Coignard, B., Tüll, P., ESCMID Study Group for Clostridium difficile. EU member states, European centre for disease prevention and control, emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 12:Suppl 6 (2006), 2–18, 10.1111/j.1469-0691.2006.01580.x.
4. [4] Davies, K.A., Longshaw, C.M., Davis, G.L., Bouza, E., Barbut, F., Barna, Z., Delmée, M., Fitzpatrick, F., Ivanova, K., Kuijper, E., Macovei, I.S., Mentula, S., Mastrantonio, P., von Müller, L., Oleastro, M., Petinaki, E., Pituch, H., Norén, T., Nováková, E., Nyč, O., Rupnik, M., Schmid, D., Wilcox, M.H., Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect. Dis. 14 (2014), 1208–1219, 10.1016/S1473-3099(14)70991-0.
5. [5] Davies, K.A., Ashwin, H., Longshaw, C.M., Burns, D.A., Davis, G.L., Wilcox, M.H., EUCLID study group, Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Eurosurveillance, 21, 2016, 10.2807/1560-7917.ES.2016.21.29.30294.
6. [6] Bauer, M.P., Notermans, D.W., van Benthem, B.H., Brazier, J.S., Wilcox, M.H., Rupnik, M., Monnet, D.L., van Dissel, J.T., Kuijper, E.J., Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377 (2011), 63–73, 10.1016/S0140-6736(10)61266-4.
7. [7] Polivkova, S., Krutova, M., Petrlova, K., Benes, J., Nyc, O., Clostridium difficile ribotype 176-A predictor for high mortality and risk of nosocomial spread?. Anaerobe 40 (2016), 35–40, 10.1016/j.anaerobe.2016.05.002.
8. [8] Barbut, F., Mastrantonio, P., Delmée, M., Brazier, J., Kuijper, E., Poxton, I., European Study Group on Clostridium difficile (ESGCD), Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 13 (2007), 1048–1057, 10.1111/j.1469-0691.2007.01824.x.
9. [9] Freeman, J., Vernon, J., Morris, K., Nicholson, S., Todhunter, S., Longshaw, C., Wilcox, M.H., Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clin. Microbiol. Infect., 21, 2015, 10.1016/j.cmi.2014.09.017 248.e9-248.e16.
10. [10] Novak, A., Spigaglia, P., Barbanti, F., Goic-Barisic, I., Tonkic, M., First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital. Anaerobe 30 (2014), 18–23, 10.1016/j.anaerobe.2014.07.007.
11. [11] van Dorp, S.M., Kinross, P., Gastmeier, P., Behnke, M., Kola, A., Delmée, M., Pavelkovich, A., Mentula, S., Barbut, F., Hajdu, A., Ingebretsen, A., Pituch, H., Macovei, I.S., Jovanović, M., Wiuff, C., Schmid, D., Olsen, K.E., Wilcox, M.H., Suetens, C., Kuijper, E.J., European Clostridium difficile Infection Surveillance Network (ECDIS-Net) on behalf of all participants, Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013. Eurosurveillance, 21, 2016, 10.2807/1560-7917.ES.2016.21.29.30293.
12. [12] Hojsak, I., Ferenc, T., Bojanić, K., Mišak, Z., Močić Pavić, A., Lukić-Grlić, A., Kolaček, S., Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients. Digestion 86 (2012), 6–11, 10.1159/000337357.
13. [13] Custovic, A., Smajlovic, J., Hadzic, S., Ahmetagic, S., Tihic, N., Hadzagic, H., Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit. Mater. Socio Med. 26 (2014), 7–11, 10.5455/msm.2014.26.7-11.
14. [14] Ahmetagic, S., Salkic, N., Ahmetagic, A., Custovic, A., Tihic, N., Smajlovic, J., Porobic-Jahic, H., Clostridium difficile infection in hospitalized patients at university clinical center Tuzla, Bosnia and Herzegovina: a 4 year experience. Mater. Socio Med. 25 (2013), 153–157, 10.5455/msm.2013.25.153-157.
15. [15] Korac, M., Milosevic, I., Markovic, M., Popovic, N., Ilic, M., Markovic, A., Nikolic, J., Jevtovic, D., Clostridium difficile infection: a Serbian single-center experience. J. Infect. Dev. Ctries. 9 (2015), 136–140.
16. [16] van Dorp, S.M., Notermans, D.W., Alblas, J., Gastmeier, P., Mentula, S., Nagy, E., Spigaglia, P., Ivanova, K., Fitzpatrick, F., Barbut, F., Morris, T., Wilcox, M.H., Kinross, P., Suetens, C., Kuijper, E.J., European Clostridium difficile Infection Surveillance Network (ECDIS-Net) project on behalf of all participants, Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Eurosurveillance, 21, 2016, 10.2807/1560-7917.ES.2016.21.29.30292.
17. [17] Janezic, S., Rupnik, M., Molecular typing methods for Clostridium difficile: pulsed-field gel electrophoresis and PCR ribotyping. Methods Mol. Biol. Clifton N. J. 646 (2010), 55–65, 10.1007/978-1-60327-365-7_4.
18. [18] Pituch, H., Obuch-Woszczatyński, P., Lachowicz, D., Wultańska, D., Karpiński, P., Młynarczyk, G., van Dorp, S.M., Kuijper, E.J., Polish Clostridium difficile Study Group. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Eurosurveillance, 20, 2015, 10.2807/1560-7917.ES.2015.20.38.30025.